SkyView Investment Advisors, LLC

Position in ABBV — AbbVie Inc.

CIK 1848237 SHREWSBURY, NJ

Position in ABBV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$399,964

-$17,030 QoQ

Shares Held

1,839

+0.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

SkyView Investment Advisors, LLC holds $5,693,586 across 8 Drug Manufacturers - General names. ABBV ranks #6 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	7,141	$1,408,348
2	PFE	Pfizer Inc	44,796	$1,257,871
3	GILD	Gilead Sciences, Inc.	5,942	$828,136
4	NVO	Novo Nordisk A S	19,010	$698,617
5	SNY	Sanofi	11,565	$557,201
6	ABBV	AbbVie Inc. This page	1,839	$399,964
7	AMGN	Amgen Inc	789	$277,609
8	MRK	Merck & Co., Inc.	2,210	$265,840

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$399,964	1,839	+0.8%	Shares	Sole	2026-05-15
2025-12-31	$416,994	1,825	-20.5%	Shares	Sole	2026-02-18
2025-09-30	$531,384	2,295	+0.1%	Shares	Sole	2026-02-13
2025-06-30	$425,626	2,293	+12.6%	Shares	Sole	2025-08-15
2025-03-31	$426,582	2,036	+2162.2%	Shares	Sole	2025-08-15
2023-09-30	$13,415	90	-96.0%	Shares	Sole	2023-11-17
2023-06-30	$300,043	2,227	+1.3%	Shares	Sole	2023-08-15
2023-03-31	$350,454	2,199	+2.6%	Shares	Sole	2023-05-18
2022-12-31	$346,330	2,143	-31.1%	Shares	Sole	2023-02-16
2022-09-30	$417,527	3,111	+9.9%	Shares	Sole	2022-11-17
2022-06-30	$433,595	2,831	+34.6%	Shares	Sole	2022-11-15
2022-03-31	$340,917	2,103	-5.3%	Shares	Sole	2022-05-17
2021-12-31	$300,588	2,220	+2.7%	Shares	Sole	2022-02-18
2020-12-31	$231,658	2,162	—	Shares	Sole	2021-03-02
No filing history on record for this holder in this stock.